Large Scale Transition to a Dolutegravir-based First-line ART in the South: Virological Response and Impact on HIV Drug Resistance in a Real Life Context (DoReaL Study)
Condition: HIV Infections Intervention: Sponsors: ANRS, Emerging Infectious Diseases; CIRBA, Abidjan, Ivory Coast; SEREFO, Bamako, Mali; BIOLIM/FSS/UL, Lomé, Togo Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials